Building upon these findings, our research has demonstrated that TNFAIP2 can induce the transcription of HIF1α via the Rac1-ERK-AP1 signaling pathway, thereby promoting tumor angiogenesis in breast cancer. Here, FOS is linked to breast carcinoma.